Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel
Journal cover image

Pure red cell aplasia following pegylated interferon alpha treatment.

Publication ,  Journal Article
Arcasoy, MO; Rockey, DC; Heneghan, MA
Published in: Am J Med
October 15, 2004

Duke Scholars

Published In

Am J Med

DOI

ISSN

0002-9343

Publication Date

October 15, 2004

Volume

117

Issue

8

Start / End Page

619 / 620

Location

United States

Related Subject Headings

  • Red-Cell Aplasia, Pure
  • Recombinant Proteins
  • Postoperative Complications
  • Polyethylene Glycols
  • Middle Aged
  • Liver Transplantation
  • Interferon-alpha
  • Interferon alpha-2
  • Humans
  • Hepatitis C
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Arcasoy, M. O., Rockey, D. C., & Heneghan, M. A. (2004). Pure red cell aplasia following pegylated interferon alpha treatment. Am J Med, 117(8), 619–620. https://doi.org/10.1016/j.amjmed.2004.04.023
Arcasoy, Murat O., Don C. Rockey, and Michael A. Heneghan. “Pure red cell aplasia following pegylated interferon alpha treatment.Am J Med 117, no. 8 (October 15, 2004): 619–20. https://doi.org/10.1016/j.amjmed.2004.04.023.
Arcasoy MO, Rockey DC, Heneghan MA. Pure red cell aplasia following pegylated interferon alpha treatment. Am J Med. 2004 Oct 15;117(8):619–20.
Arcasoy, Murat O., et al. “Pure red cell aplasia following pegylated interferon alpha treatment.Am J Med, vol. 117, no. 8, Oct. 2004, pp. 619–20. Pubmed, doi:10.1016/j.amjmed.2004.04.023.
Arcasoy MO, Rockey DC, Heneghan MA. Pure red cell aplasia following pegylated interferon alpha treatment. Am J Med. 2004 Oct 15;117(8):619–620.
Journal cover image

Published In

Am J Med

DOI

ISSN

0002-9343

Publication Date

October 15, 2004

Volume

117

Issue

8

Start / End Page

619 / 620

Location

United States

Related Subject Headings

  • Red-Cell Aplasia, Pure
  • Recombinant Proteins
  • Postoperative Complications
  • Polyethylene Glycols
  • Middle Aged
  • Liver Transplantation
  • Interferon-alpha
  • Interferon alpha-2
  • Humans
  • Hepatitis C